{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T21:50:41Z","timestamp":1694987441467},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00277-012-1511-5","type":"journal-article","created":{"date-parts":[[2012,7,22]],"date-time":"2012-07-22T03:04:11Z","timestamp":1342926251000},"page":"1969-1970","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated?"],"prefix":"10.1007","volume":"91","author":[{"given":"M.","family":"Bellido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. H. J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. W. G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A. W.","family":"te Boekhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,4]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2011.04562.x","volume":"10","author":"STA Bijnen van","year":"2012","unstructured":"van Bijnen STA, van Heerde WL, Muus P (2012) Mechanism and clinical implications of thrombosis in paroxysmal nocuternal hemoglobinuria. J Thrombo Haemost 10:1\u201310","journal-title":"J Thrombo Haemost"},{"key":"1511_CR2","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, D\u00fchrsen U et al (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patient with paroxysmal nocturnal hemoglobinuria. Blood 110:4123\u20134128","journal-title":"Blood"},{"key":"1511_CR3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P et al (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653\u20131662","journal-title":"JAMA"},{"key":"1511_CR4","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM et al (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117:6786\u20136792","journal-title":"Blood"},{"key":"1511_CR5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","volume":"153","author":"L Luzzatto","year":"2011","unstructured":"Luzzatto L, Gianfaldoni G, Notaro R (2011) Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol 153:709\u2013720","journal-title":"Br J Haematol"},{"key":"1511_CR6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V82.4.1192.1192","volume":"82","author":"T Wiedmer","year":"1993","unstructured":"Wiedmer T, Hall SE, Ortel TL et al (1993) Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192\u20131196","journal-title":"Blood"},{"issue":"15","key":"1511_CR7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000126837.88743.DD","volume":"109","author":"A Schafer","year":"2004","unstructured":"Schafer A, Wiesmann F, Neubauer S, Eigenthaler M, Bauersachs J, Channon KM (2004) Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 109(15):1819\u20131822","journal-title":"Circulation"},{"key":"1511_CR8","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.1016\/S0021-9258(19)47291-8","volume":"264","author":"PJ Sims","year":"1989","unstructured":"Sims PJ, Rollins SA, Wiedmer T (1989) Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. J Biol Chem 264:19228\u201319235","journal-title":"J Biol Chem"},{"key":"1511_CR9","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1182\/blood-2009-03-195966","volume":"113","author":"RA Brodsky","year":"2009","unstructured":"Brodsky RA, How I (2009) treat paroxysmal nocturnal hemoglobinuria. Blood 113:6522\u20136527","journal-title":"Blood"},{"key":"1511_CR10","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1023\/A:1026467219850","volume":"45","author":"KS Kumar","year":"2000","unstructured":"Kumar KS, Malet PF, Rutherford C (2000) Paroxysmal nocturnal hemoglobinuria with no evidence of hemolysis presenting as Budd-Chiari syndrome. Dig Dis Sci 45:2238\u20132239","journal-title":"Dig Dis Sci"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1511-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T16:14:59Z","timestamp":1642868099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1511-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,4]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1511-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,4]]}}}